Boundless Bio Competitors and Similar CompaniesClear all
Boundless Bio's competitors and similar companies include ADC Therapeutics and Curis.
 Boundless Bio Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers. |  ADC Therapeutics ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers. |  Curis Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers. | |
Founding Date | Founding Date 2019 | Founding Date 2010 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Epalinges, CH HQ London, GB New Providence, US | Locations Lexington, US HQ Lexington, US |
Employees | Employees 2856% decrease | Employees 1162% increase | Employees 3144% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 295.9 m | Valuation ($) 29.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $81.4m (FY, 2025) | Revenue (est.) $9.4m (FY, 2025) |
Net income | Net income ($58.2m) (FY, 2025) | Net income ($142.6m) (FY, 2025) | Net income ($7.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 46.4m | Total funding raised $ 526m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ADC Therapeutics
HQ
Epalinges, CH
Employees
116↑ 2% increase
ADC Therapeutics is a biotechnology company that develops drug conjugates for the treatment of both solid and haematological cancers.
View companyCuris
HQ
Lexington, US
Employees
31↓ 44% decrease
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
View company